Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
FDA supplemental approval of a Risk Evaluation and Mitigation Strategy (REMS) for lenalidomide; does not contain clinical trial data or efficacy evidence.